跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL
Approved
STANDARD
NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL
Tarbis Farma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 30, 2020
Approval ID
8a98ae54aaecff74
Company
Tarbis Farma S.L.
Type
Standard
Approval Details
Approval Id
8a98ae54aaecff74
Drug Cima Aemps Name
NOVAG ANTIGRIPAL GRANULADO PARA SOLUCION ORAL
Register Number
85217
Holder Company Name
Tarbis Farma S.L.
Marketing Company Name
Tarbis Farma S.L.
Authorization Date
2020-06-30
Dosage Form
GRANULADO PARA SOLUCIÓN ORAL
Dose
650 / 15.58 / 4 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
Yes
Company Name
Tarbis Farma S.L.
Active Ingredients
PARACETAMOL
650 mg
FENILEFRINA BITARTRATO
15,58 mg
CLORFENAMINA MALEATO
4 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 30, 2020
Approval ID
8a98ae54aaecff74
Type
Standard
Back to CIMA-AEMPS Approvals
